A group of prestigious researchers from the University of Miami and the Instituto Distrital de Ciencia, Biotecnología e Innovación en Salud (IDCBIS), of the Mayor's Office of Bogota, are working together on the treatment of type I diabetes in Colombia.

Camillo Ricordi, Director of the Diabetes Research Institute; Diego Correa, Assistant Professor at the Miller School of Medicine of the University of Miami; Bernardo Camacho, Director of IDCBIS and Luis Gonzalo Morales Sánchez, Secretary of Health, met in the country's capital to exchange knowledge and experiences on the treatment of the disease.

"These prestigious scientists will share with us successful techniques and technologies for the transplantation of pancreatic islets in Type I Diabetes; what we are looking for is that patients, especially children and adolescents are not dependent on insulin and have a better quality of life," explained Bernardo Camacho, director of the IDCBIS.

In the last decade, important clinical evidence has been generated that shows the safety and efficacy of this treatment based on cell therapy, especially from the experience of the Diabetes Research Institute (DRI) of the Miller School of Medicine of the University of Miami. This group, led by Dr. Camllo Ricordi, has been the world pioneer in pancreatic islet transplantation, with more than 25 years of experience in the application of this procedure.

Pancreatic Islet Transplantation can be improved ostensibly with the help of other therapies, on which the Cell Therapy Unit of IDCBIS is working.